http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106226531-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2016-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2018-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106226531-B |
titleOfInvention | ANGPT2 is screening or is preparing to diagnose or treat the application in angiomatous drug |
abstract | The invention discloses the ANGPT2 or TIE2 of phosphorylation to screen or prepare to diagnose or treat the application in angiomatous drug, and the hemangioma is characterized by the pericyte covering for the vascular endothelial cell and reduction that individual layer is expanded.The present invention provides new target spot for the design of the hemangiomas new drug such as CCM, and new method and new approaches are provided for angiomatous treatment. |
priorityDate | 2016-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 282.